Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Interventional × Giant Cell Tumor of Bone × Clear all

Phase

Status

Sponsor Class

OTHER 7 INDUSTRY 4 NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 191 Carcinoma, Non-Small-Cell Lung 135 Lung Neoplasms 116 Lymphoma 106 Prostatic Neoplasms 102 Leukemia 88 Ovarian Neoplasms 87 Central Nervous System Neoplasms 87 Colorectal Neoplasms 84 Sarcoma 79 Head and Neck Neoplasms 77 Precursor Cell Lymphoblastic Leukemia-Lymphoma 76 Multiple Myeloma 75 Squamous Cell Carcinoma of Head and Neck 67 Rectal Neoplasms 61 Neoplasm Metastasis 56 Carcinoma, Ovarian Epithelial 55 Uterine Cervical Neoplasms 54 Brain Neoplasms 53 Leukemia, Myeloid, Acute 52 Astrocytoma 52 Colonic Neoplasms 51 Fallopian Tube Neoplasms 48 Lymphoma, Large B-Cell, Diffuse 45 Glioblastoma 45 Urinary Bladder Neoplasms 44 Melanoma 42 Burkitt Lymphoma 41 Neuroblastoma 40 Hodgkin Disease 40

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03620149 2021-01-06

REDUCE

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated

Giant Cell Tumor of Bone

Data powered by HemOnc (CC BY 4.0) Colophon ⚡